Literature DB >> 8559617

Longitudinal data on growth and final height in diabetic children.

M V Du Caju1, R P Rooman, L op de Beeck.   

Abstract

The available data on growth in children with insulin-dependent diabetes mellitus are conflicting and are mainly derived from cross-sectional studies. In this longitudinal study, height, weight, skeletal age, and pubertal development were recorded until final height was attained in 46 children (22 girls and 24 boys) with onset of diabetes before the age of 10 y. At the onset of diabetes, height SD score (SDS) averaged 0.41 in girls and 0.56 in boys, which was normal when corrected for the secular trend. Prepubertal growth was unaffected in both sexes. Diabetic boys had a marked delay in onset of puberty (mean age at genitalia stage 2: 13.7 y) but attained a normal final height (final height SDS: 0.48 +/- 0.89). In girls final height was slightly reduced (height SDS 0.27 +/- 0.97) due to a suboptimal pubertal growth spurt. Mean pubertal height gain in girls was 16.6 cm and mean age at breast stage 2 was 11.6 y. Diabetic girls also tended to become obese during puberty. Skeletal maturation was normal at all ages. These data suggest that conventional therapy does not guarantee optimal growth, especially in girls.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8559617     DOI: 10.1203/00006450-199510000-00022

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes.

Authors:  Kirstie K Danielson; Mari Palta; Catherine Allen; Donn J D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2005-10-04       Impact factor: 5.958

Review 2.  Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.

Authors:  Manish Raisingani; Brar Preneet; Brenda Kohn; Shoshana Yakar
Journal:  Growth Horm IGF Res       Date:  2017-04-28       Impact factor: 2.372

3.  Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?

Authors:  Carly S Gordon; Antonio S Serino; Matthew P Krause; Jonathan E Campbell; Enzo Cafarelli; Olasunkanmi A J Adegoke; Thomas J Hawke; Michael C Riddell
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

4.  In vitro biological-to-immunological ratio of serum gonadotropins throughout male puberty in children with insulin-dependent diabetes mellitus.

Authors:  Elisa Nishimura; Daniela Söderlund; Cecilia Castro-Fernández; Teresa Zariñán; Juan Pablo Méndez; Alfredo Ulloa-Aguirre
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

Review 5.  Linear Growth in Children and Adolescents with Type 1 Diabetes Mellitus.

Authors:  Elisa Santi; Giorgia Tascini; Giada Toni; Maria Giulia Berioli; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-09-30       Impact factor: 3.390

6.  Oral Health Status of Children Living with Type 1 Diabetes Mellitus.

Authors:  Dorottya Banyai; Daniel Vegh; Adam Vegh; Marta Ujpal; Michael Payer; Zita Biczo; Zsuzsanna Triebl; Khaled Mukaddam; Valentin Herber; Norbert Jakse; Zsolt Nemeth; Peter Hermann; Noémi Rózsa
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

Review 7.  Growth abnormalities in children with type 1 diabetes, juvenile chronic arthritis, and asthma.

Authors:  Cosimo Giannini; Angelika Mohn; Francesco Chiarelli
Journal:  Int J Endocrinol       Date:  2014-02-04       Impact factor: 3.257

8.  Characteristics of Selected Somatic and Motor Abilities of Youth Soccer Players with Diabetes Type 1 Treated with Insulin Pump Therapy.

Authors:  Magdalena Krzykała; Katarzyna Domaszewska; Małgorzata Woźniewicz-Dobrzyńska; Jakub Kryściak; Agata Konarska; Aleksandra Araszkiewicz; Dorota Zozulińska-Ziółkiewicz; Andrzej Gawrecki; Grzegorz Biegański; Jan M Konarski
Journal:  Int J Environ Res Public Health       Date:  2021-03-27       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.